ArticleNPJ digital medicine2025
Multi-dimensional omics integrated machine learning framework identifies macrophage-fibroblast-tumor co-infiltration patterns to predict prognosis in gastric cancer.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Review
- Multi-omics mapping of TIMP1-associated stromal-myeloid remodeling in autoimmune gastritis and gastric cancer.Hereditas · 2026Article
- Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies.Molecular cancer · 2026Review
- Gastric Cancer: Pathobiology and Therapeutics.MedComm · 2026Review
- Review
- Formation and remodeling of immunological niches in solid tumors: organ-specific architectures, inflammatory parallels, and therapeutic reprogramming.Frontiers in immunology · 2026Review
- Editorial: Artificial intelligence in multi-omics: advancing tumor metastasis prediction and mechanism analysis.Frontiers in cell and developmental biology · 2026Article
- Multiomics Analysis of Nucleotide Metabolism Highlights the Important Role of Adenylate Kinase 4 in Pancreatic Cancer.Human mutation · 2026Article
- Integrated single-cell and bulk RNA sequencing analyses identify a myeloid state-related gene signature for molecular subtyping in stomach adenocarcinoma.Frontiers in immunology · 2026Article
- Spatial immune archetypes in gastric and colorectal cancer: a proposed conceptual framework for immunotherapy resistance and therapeutic remodeling.Frontiers in immunology · 2026Review
- Spatial multi-omics technologies in gastric cancer: applications and advances.Frontiers in immunology · 2026Review
- Targeting Tumor-Associated Macrophages to Reshape the Immuno-Mechanical Landscape: Molecular Mechanisms and Therapeutic Strategies.International journal of biological sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Gastric cancer (GC), of which cases with peritoneal metastasis are particularly challenging, retains its position of being highly complex and remarkably resistant to therapy. Understanding the spatial heterogeneity and leveraging recent technologies such as machine learning to uncover explanatory patterns remains critical to truly understanding this disease. Here, we conducted spatial transcriptomics analysis to identify distinct niches within GC tissues. Among these, a niche enriched with fibroblasts and macrophages exhibited a striking spatial co-infiltration pattern with tumor cells dominant niches. Further validation by multiplex immunofluorescence highlighted the coordinated cellular interactions that characterize the TME. Through integration of sc-RNA with bulk RNA sequencing, we identified DAB2⁺ TAMs and ACTA2⁺ myCAFs as the main contributors to this co-infiltration pattern. NicheNet analysis further revealed that the PLAU-PLAUR signaling axis holds a central regulatory role in the communication between macrophages, fibroblasts and tumor cells. Given the prognostic value of this spatial pattern, we additionally applied transfer learning based on an ImageNet pre-trained ResNet-50 model to develop a machine learning framework that can accurately recognize the macrophage-fibroblast-malignant cell co-infiltration pattern, called Gastric-Discovery. Potentially, Gastric-Discovery could be a tool for precise patient stratification and provides novel insights into the dynamic architecture of the TME.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.